Evofem Biosciences, Inc. (EVFM): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2022-05-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

126.69M

As of 2025-12-31

132.53M

As of 2026-06-30

n/m

3-year compound annual growth

2014-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	126.69M	+11.8%	2026-03-11, Balance as of period end
2024-12-31	113.36M	+466.6%	2026-03-11, Balance as of period end
2023-12-31	20.01M	n/m	2025-03-24, Balance as of period end
2022-12-31	984.8K	-90.9%	2024-03-27, Balance as of period end
2021-12-31	10.83M	n/c	2023-04-27, Balance as of period end
2020-12-31	81.35M	+69.0%	2022-03-10, Balance as of period end
2019-12-31	48.14M	+86.1%	2021-03-04, Balance as of period end
2018-12-31	25.87M	n/m	2020-03-12, Balance as of period end
2017-12-31	2.08M	n/c	2019-03-01, Balance as of period end
2016-12-31	2.30M	-83.2%	2018-02-26, Balance as of period end
2015-12-31	13.75M	+0.6%	2017-03-23, Balance as of period end
2014-12-31	13.67M	n/a	2016-03-29, Balance as of period end